Skip to main content

Table 1 Characteristics of the dementia patients, Swedish Dementia Registry 2007 to 2012

From: Cardiovascular medication burden in dementia disorders: a nationwide study of 19,743 dementia patients in the Swedish Dementia Registry

 

Total

AD

MixD

VaD

DLB

FTD

PDD

(n= 19,743)

(n= 8,139; 41%)

(n= 5,203; 27%)

(n= 4,982; 25%)

(n= 605; 3%)

(n= 409; 2%)

(n= 405; 2%)

Age

       

 Mean

78.9 ± 7.8

77.7 ± 8.1

81.0 ± 6.5

80.0 ± 7.4

76.5 ± 7.1

70.0 ± 10.0

75.2 ± 7.0

 Range

27 to 103

27 to 99

52 to 100

33 to 103

53 to 94

39 to 96

49 to 94

Gender, n (%)

       

 Female

11,537

5,328

3,075

2,514

236

228

156

 

(58.0%)

(65.5%)

(59.1%)

(50.5%)

(39.0%)

(55.7%)

(38.5%)

 Male

8,206

2,811

2,128

2,468

369

181

249

 

(42.0%)

(34.5%)

(40.9%)

(49.5%)

(61.0%)

(44.3%)

(61.5%)

MMSE

       

 Mean

21.3 ± 5.0

21.6 ± 5.0

21.0 ± 5.0

21.2 ± 4.9

21.5 ± 5.0

23.6 ± 5.0

21.0 ± 5.1

 Range

0 to 30

0 to 30

0 to 30

0 to 30

0 to 30

3 to 30

6 to 30

Living alone (%)

44.3

43.0

48.7

45.7

34.7

33.0

22.7

CV drugs (%)

70.0

59.4

76.9

84.3

59.5

53.3

57.5

ChEIs (%)

49.8

73.0

53.9

7.8

74.4

6.8

54.6

NMDA antagonists (%)

10.5

9.8

17.0

4.7

15.0

4.9

11.6

Number of drugs

       

 Mean

5.0 ± 3.1

4.0 ± 2.8

5.4 ± 3.1

6.2 ± 3.2

4.8 ± 2.9

3.7 ± 2.8

6.5 ± 3.2

 Range

0 to 24

0 to 21

0 to 24

0 to 23

0 to 17

0 to 13

0 to 19

  1. AD, Alzheimer’s disease; ChEI, cholinesterase inhibitor; CV, cardiovascular; DLB, dementia with Lewy bodies; FTD, frontotemporal dementia; MixD, mixed dementia; MMSE, Mini Mental State Examination; NMDA, N-methyl-d-aspartate; PDD, Parkinson’s disease dementia; VaD, vascular dementia.